SEC 13F Intelligence

Octagon Capital Advisors LP / TRVI

Octagon Capital Advisors LP’s Trevi Therapeutics Inc Position

Does Octagon Capital Advisors LP own Trevi Therapeutics Inc (TRVI)? Yes — 1.49M shares worth $18M (+1.96% of its 13F portfolio) as of Q1 2026, down from 2.81M shares the prior filed quarter.

Position Value
$18M
Q1 2026
Shares
1.49M
% of Portfolio
+1.96%
Quarters Held
5
currently held

Position History TRVI

Reported value by quarter
Q1 ’25: $21MQ1 ’25Q2 ’25: $20MQ2 ’25Q3 ’25: $26MQ3 ’25Q4 ’25: $35MQ4 ’25Q1 ’26: $18MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.49M$18M+1.96%
Q4 20252.81M$35M+4.28%
Q3 20252.81M$26M+3.90%
Q2 20253.67M$20M+4.41%
Q1 20253.32M$21M+4.04%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Octagon Capital Advisors LP’s full portfolio or all institutional holders of TRVI.